BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23458517)

  • 1. A different look at the management of chronic hepatitis B in a resource-constrained country.
    Jia J
    J Viral Hepat; 2013 Apr; 20 Suppl 1():1. PubMed ID: 23458517
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.
    Marcellin P; Asselah T
    J Hepatol; 2005 Dec; 43(6):920-3. PubMed ID: 16246449
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil.
    Li Y; Zhang Y; Wang JP; Lian JQ; Bai XF
    J Viral Hepat; 2013 Apr; 20 Suppl 1():46-51. PubMed ID: 23458524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B--new goals, new treatment.
    Lai CL; Yuen MF
    N Engl J Med; 2008 Dec; 359(23):2488-91. PubMed ID: 19052131
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.
    Lampertico P
    J Hepatol; 2009 Apr; 50(4):644-7. PubMed ID: 19231017
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].
    DING JG; SUN QF; FU RQ; WU YH; HONG L
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):387-8. PubMed ID: 19497209
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
    Aloman C; Wands JR
    Hepatology; 2003 Dec; 38(6):1584-7. PubMed ID: 14655682
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy for chronic hepatitis B: a one-two knockout punch, or a swing and a miss?
    Chun S; Zucker SD
    Gastroenterology; 2006 Feb; 130(2):613-4; discussion 514-5. PubMed ID: 16472619
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
    Lin Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute liver failure resulting from discontinuation of nucleoside analogues in chronic hepatitis B patients: a report of two cases.
    Wang J; Wang M; Huang Y
    Scand J Infect Dis; 2013 Feb; 45(2):158-60. PubMed ID: 22830672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
    Zarski JP
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B virus with primary resistance to adefovir.
    Chang TT; Lai CL
    N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic hepatitis B: from old braids and new brooms].
    Krankenpfl J; 2005; 43(7-10):192-3. PubMed ID: 16515264
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
    Mohamadnejad M
    Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389
    [No Abstract]   [Full Text] [Related]  

  • 17. Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
    Liaw YF
    Hepatology; 2007 Feb; 45(2):266-8. PubMed ID: 17256763
    [No Abstract]   [Full Text] [Related]  

  • 18. Adefovir for lamivudine resistant HBV: more than meets the eye.
    Di Marco V; Craxì A
    J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
    [No Abstract]   [Full Text] [Related]  

  • 19. [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
    MMW Fortschr Med; 2009 Apr; 151(18):62-3. PubMed ID: 19769080
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B genotypes and response to adefovir treatment in patients with HBV chronic infection.
    Scotto G; Fazio V
    J Infect; 2010 May; 60(5):399-401. PubMed ID: 20226208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.